Zobrazeno 1 - 10
of 129
pro vyhledávání: '"Weegink, Christine"'
Autor:
Weegink, Christine Joanne.
Proefschrift Universiteit van Amsterdam.
Met lit. opg. - Met samenvatting in het Nederlands.
Met lit. opg. - Met samenvatting in het Nederlands.
Externí odkaz:
http://dare.uva.nl/document/74129
Autor:
Lenz, Oliver, de Bruijne, Joep, Vijgen, Leen, Verbinnen, Thierry, Weegink, Christine, Van Marck, Herwig, Vandenbroucke, Ina, Peeters, Monika, Simmen, Kenneth, Fanning, Greg, Verloes, Rene, Picchio, Gaston, Reesink, Hendrik
Publikováno v:
In Gastroenterology November 2012 143(5):1176-1178
Autor:
Reesink, Henk W., Fanning, Gregory C., Farha, Khalid Abou, Weegink, Christine, Van Vliet, André, van 't Klooster, Gerben, Lenz, Oliver, Aharchi, Fatima, Mariën, Kris, Van Remoortere, Pieter, de Kock, Herman, Broeckaert, Fabrice, Meyvisch, Paul, Van Beirendonck, Els, Simmen, Kenneth, Verloes, René
Publikováno v:
In Gastroenterology March 2010 138(3):913-921
Autor:
Brouwer, Johannes T, Nevens, Frederik, Bekkering, Frank C, Bourgeois, Nadine, Van Vlierberghe, Hans, Weegink, Christine J, Lefebvre, Véronique, van Hattum, Jan, Henrion, Jean, Delwaide, Jean, Hansen, Bettina E, Schalm, Solko W ∗, for the Benelux Study Group on Treatment of Chronic Hepatitis C
Publikováno v:
In Journal of Hepatology 2004 40(4):689-695
Autor:
Aronson, Sem J., de Bruijne, Joep, Schinkel, Janke, Weegink, Christine J., van der Valk, Marc, Reesink, Hendrik W.
Publikováno v:
Nederlands tijdschrift voor geneeskunde, 156(10). Bohn Stafleu van Loghum
Worldwide approximately 130-210 million people suffer from chronic hepatitis C. Adequate antiviral therapy reduces morbidity and mortality caused by chronic hepatitis C and prevents further spread of the hepatitis C-virus (HCV). The current standard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::d494c0c8ff713956a35bc8ed003191a7
https://pure.amc.nl/en/publications/nieuwe-klasse-medicijnen-voor-chronische-hepatitis-c(f63ffe77-463a-4320-99b4-b0aa02f868c5).html
https://pure.amc.nl/en/publications/nieuwe-klasse-medicijnen-voor-chronische-hepatitis-c(f63ffe77-463a-4320-99b4-b0aa02f868c5).html
Autor:
Takkenberg, Bart, Terpstra, Valeska, Zaaijer, Hans, Weegink, Christine, Dijkgraaf, Marcel, Jansen, Peter, Beld, Marcel, Reesink, Hendrik
Publikováno v:
Journal of gastroenterology and hepatology, 26(10), 1527-1535. Wiley-Blackwell
We investigated whether intrahepatic markers could predict response in chronic hepatitis B virus (HBV) patients treated with peg-interferon and adefovir for 48 weeks. Intrahepatic covalently closed circular DNA (cccDNA), total intrahepatic HBV DNA an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::06c4912f5fa3888c87dfc71417e35588
https://pure.amc.nl/en/publications/intrahepatic-response-markers-in-chronic-hepatitis-b-patients-treated-with-peginterferon-alpha2a-and-adefovir(65f34021-7d63-4a2c-8ea9-095595436138).html
https://pure.amc.nl/en/publications/intrahepatic-response-markers-in-chronic-hepatitis-b-patients-treated-with-peginterferon-alpha2a-and-adefovir(65f34021-7d63-4a2c-8ea9-095595436138).html
Autor:
Schreuder, Tim C. M. A., Gelderblom, Huub C., Weegink, Christine J., Hamann, Dörte, Reesink, Henk W., DeVries, J. Hans, Hoekstra, Joost B. L., Jansen, Peter L. M.
Publikováno v:
Liver international, 28(1), 39-46. Wiley-Blackwell
BACKGROUND: Development of diabetes mellitus (DM) during or shortly after treatment with interferon alpha (IFN-alpha) in patients with chronic hepatitis C virus (HCV) infection has been reported sporadically. We prospectively screened for DM during a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::18466c36a5713acb168c4a82c9142229
https://pure.amc.nl/en/publications/high-incidence-of-type-1-diabetes-mellitus-during-or-shortly-after-treatment-with-pegylated-interferon-alpha-for-chronic-hepatitis-c-virus-infection(d298c868-40f2-43ed-a05c-00b8811103cf).html
https://pure.amc.nl/en/publications/high-incidence-of-type-1-diabetes-mellitus-during-or-shortly-after-treatment-with-pegylated-interferon-alpha-for-chronic-hepatitis-c-virus-infection(d298c868-40f2-43ed-a05c-00b8811103cf).html
Autor:
Gelderblom, Huub C., Reesink, Henk W., Beld, Marcel G. H. M., Weegink, Christine J., Jansen, Peter L. M., Dijkgraaf, Marcel G. W., Zaaijer, Hans L.
Publikováno v:
Antiviral therapy, 12(3), 423-427. International Medical Press Ltd
BACKGROUND: In chronic hepatitis C patients with an initial virological response (IVR) during antiviral therapy (that is, HCV RNA becomes negative before week 16 of treatment) the significance of reappearing viraemia below the detection limit of PCR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::52c22f7621f72a7d114446181aa68d73
https://pure.amc.nl/en/publications/lowlevel-hcv-viraemia-after-initial-response-during-antiviral-therapy-transcriptionmediated-amplification-predicts-treatment-failure(a92457ca-0145-4c01-86cb-2bfe8b474071).html
https://pure.amc.nl/en/publications/lowlevel-hcv-viraemia-after-initial-response-during-antiviral-therapy-transcriptionmediated-amplification-predicts-treatment-failure(a92457ca-0145-4c01-86cb-2bfe8b474071).html
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.